Navigation Links
American Association for Cancer Research to honor leading researchers at breast cancer symposium

PHILADELPHIA The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.

The awards will be given by the American Association for Cancer Research, which together with the Cancer Therapy and Research Center at The University of Texas Health Science Center and Baylor College of Medicine, conduct the meeting for nearly 9,000 attendees.

Robert Weinberg, Ph.D., professor of biology at the Massachusetts Institute of Technology, will present the 2009 AACR Distinguished Lectureship in Breast Cancer Research. Weinberg is the author of The Biology of Cancer.

His laboratory is currently studying the ability of breast cancer cells to thrive and proliferate at various locations throughout the human body in a devastating process called metastasis. Their previous research has shown that this activity is dependent on stromal cells from bone marrow, and they are working to understand the nature of these cells and what causes their stimulation.

Charles M. Perou, Ph.D., associate professor of genetics and pathology at the Lineberger Cancer Center at the University of North Carolina, will receive the 2009 AACR Outstanding Investigator Award for Breast Cancer Research, which is funded by Susan G. Komen for the Cure.

Perou's lab focuses on genetic technology and its application to breast cancer. He initially demonstrated that breast cancer can be divided into five distinct molecular subtypes and that those subtypes could be applied to certain demographic populations to predict risk.

Both awardees will deliver a 25-minute lecture at this year's San Antonio Breast Cancer Symposium.

The CTRC-AACR San Antonio Breast Cancer Symposium is a four-day program that presents a balance of clinical, translational and basic research. It provides a forum for interaction, communication and education for a broad spectrum of researchers, health care professionals and those with a special interest in breast cancer.

The majority of participants are scientists and researchers. At least year's meeting, more than 8,900 people attended from 92 countries. The audience was composed of 46 percent medical doctors and 9 percent basic research scientists.


Contact: Jeremy Moore
American Association for Cancer Research

Related biology news :

1. Americans concerned about heart health, but not proactive enough to prevent it
2. UF to get $64 million over 6 years to study disability prevention in older Americans
3. Nanotechnology and synthetic biology: What does the American public think?
4. Tips from the American Journal of Pathology
5. Tennessee foresters helping to return chestnuts to American forests
6. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
7. American Society for Microbiology to launch new open-access journal
8. Tips from the Journals of the American Society for Microbiology
9. Anticancer compound found in American mayapple
10. The American Phytopathological Society announces 2009 awardees
11. American College of Preventive Medicine releases lifestyle medicine literature review
Post Your Comments:
(Date:10/4/2017)... 4, 2017  GCE Solutions, a global clinical research organization (CRO), ... anonymization solution on October 4, 2017. Shadow is designed to assist ... with policy 0070 of the European Medicines Agency (EMA) in meeting ... ... ...
(Date:6/30/2017)... 30, 2017 Today, American Trucking Associations ... of face and eye tracking software, became the ... program. "Artificial intelligence and advanced ... monitor a driver,s attentiveness levels while on the ... to detect fatigue and prevent potential accidents, which ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology: